RVPH
RVPH
NASDAQ · Pharmaceuticals

Reviva Pharmaceuticals Holdi

$0.61
+0.03 (+4.72%)
As of Jun 21, 10:50 PM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +1,927.9% upside
Low Target $10.29
Average Target $12.37
High Target $18.62
Current Price $0.61
Current
$0.61
Target
$12.37
$10.29 $12.37 avg $18.62
Scenario Analysis
Bear Case
$10.29
1,586.9%
Low target
Base Case
$12.37
+1,927.9%
Avg target
Bull Case
$18.62
+2,952.5%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$17.20
-96.5% from high
52-Week Low
$0.26
+132.8% from low
Target vs 52W High
$12.37
-28.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +20.2%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +25.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +33.2%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +37.1%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +214.2%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +173.1%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -34.5%